9-valent CRM 197 Pneumococcal

NCT00133549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

NIH

Sponsor class

Conditions

Pneumococcal Infection

Interventions

DRUG: Placebo
BIOLOGICAL: PNU-IMUNE®23
BIOLOGICAL: Nine-valent pneumococcal conjugate (PNCRM9)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)